Chr. Hansen breaks into HMO arena with €310m Jennewein acquisition

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

22 Apr 2021 --- Specific probiotic strains have a favorable impact on stress and sleep quality of rotation shift workers, supporting immunity by extension, according to a study by... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

21 Apr 2021 --- Kyowa Hakko’s parent company, Kirin Holdings is releasing its paraprobiotic immune activator Immuse, which includes Lactococcus lactis strain Plasma, in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

15 Apr 2021 --- Chr. Hansen is spotlighting the potential of the Asia-Pacific (APAC) market in its Q2 2020/2021 results, which reveal an overall 10 percent organic sales growth in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Apr 2021 --- A combination of BioGaia’s probiotic strains Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 may help reduce fever and sore throat pain in children... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

12 Apr 2021 --- Israeli researchers based at Ben-Gurion University of the Negev (BGU) have created a new company to develop and commercialize drug candidates based on molecules... Read More

trans